Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1242.00
-3.50 (-0.28%)
< Home < Back

USFDA seeks voluntary action at Dr. Reddy's Andhra Pradesh facility

Date: 17-02-2020

The US Food and Drug Administration (USFDA) has asked Dr. Reddy's Laboratories to initiate voluntary action at its Duvvada facility in Andhra Pradesh. The company has been notified by the USFDA that the inspection classification of the Formulations Manufacturing Plant at Duvvada, Visakhapatnam is determined as Voluntary Action Initiated (VAI).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.